/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-21-09-53-38-217-67dd3722f016db2f4cd15c95.jpg)
Various UK pharmaceutical companies yesterday co-signed a report warning that future UK investment is unlikely unless the Government...
Hugo Kent-Egan
Associate (Life Sciences Regulatory), Bristows LLP
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-17-14-22-08-450-67d830102c113a118a323c20.jpg)
On Friday, the DHSC published the latest consultation to update the repayment percentage under the Statutory Scheme. This consultation...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-12-14-32-10-309-67d19aea5746d2ef9a9b9626.jpg)
HMRC has been granted permission to appeal the First-Tier Tribunal’s VAT decision in the case of Boehringer Ingelheim Ltd v HMRC. We...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-12-19-12-21-24-651-67640fc43e67bad811f6af68.jpg)
On 16 December, the DHSC announced that the 2025 headline VPAG repayment percentage for sales of “newer medicines” will be 22.9%. This...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-19-13-33-35-541-673c93af3578d9951b12158b.jpg)
We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-04-18-01-17-688-67290bed3a0558a3ea1bbb6d.jpg)
The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-10-07-10-15-46-292-6703b4d2b31cb1b0dc7145f4.jpg)
On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-07-08-11-24-21-604-668bcc65be44ae33ad10ac74.jpg)
“To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...